PMID

Data

Article Title

Organization

Design of inhibitors of Helicobacter pylori glutamate racemase as selective antibacterial agents: incorporation of imidazoles onto a core pyrazolopyrimidinedione scaffold to improve bioavailabilty.

Astrazeneca

Exploitation of structural and regulatory diversity in glutamate racemases.

Astrazeneca Global Structural Chemistry

 

The inhibition of glutamate racemase by

TBA

Potent and selective inhibitors of Helicobacter pylori glutamate racemase (MurI): pyridodiazepine amines.

Astrazeneca R&D Boston

Exploring 8-benzyl pteridine-6,7-diones as inhibitors of glutamate racemase (MurI) in gram-positive bacteria.

Astrazeneca R&D Boston

Design of Helicobacter pylori glutamate racemase inhibitors as selective antibacterial agents: a novel pro-drug approach to increase exposure.

Astrazeneca R&D Boston

Exploring 9-benzyl purines as inhibitors of glutamate racemase (MurI) in Gram-positive bacteria.

Astrazeneca R&D Boston

A review on the structures and biological activities of anti-Helicobacter pylori agents.

Mazandaran University of Medical Sciences

4-Substituted D-glutamic acid analogues: the first potent inhibitors of glutamate racemase (MurI) enzyme with antibacterial activity.

Eli Lilly